Arena Pharma (ARNA) Misses Q2 EPS by 7626c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Restructuring charges: 231K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Restructuring charges: 231K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q2 EPS of ($77.00), $76.26 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $5.52 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
